[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-344615-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-344615-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","srebp2-confers-ferroptosis-resistance-by-targeting-gpx4-in-colorectal-cancer","SREBP2 confers ferroptosis resistance by targeting GPX4 in colorectal cancer","","SREBP2 overexpression is observed across multiple malignancies, while ferroptosis is an iron-dependent form of cell death driven by lipid peroxide accumulation. This study examines how SREBP2 regulates colorectal cancer (CRC) ferroptosis resistance and the molecular mechanisms involved. SREBP2 knockdown or inhibition with Betulin, together with RNA-seq and ferroptosis rescue experiments, shows SREBP2 promotes GPX4-dependent ferroptosis evasion, while ChIP and luciferase assays identify upstream regulation by β-catenin. Targeting SREBP2 also suppresses tumor growth in vivo.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/srebp2-confers-ferroptosis-resistance-by-targeting-gpx4-in-colorectal-cancer/344615/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/srebp2-confers-ferroptosis-resistance-by-targeting-gpx4-in-colorectal-cancer/344615.png","ImageObject",300,407,{"name":42,"@type":43},"Jiven","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main goal of the study in CRC?","Question",{"text":63,"@type":64},"To determine how SREBP2 contributes to ferroptosis resistance in colorectal cancer and to clarify the underlying molecular mechanism.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does SREBP2 affect ferroptosis sensitivity in CRC cells?",{"text":68,"@type":64},"SREBP2 increases GPX4 transcription, which reduces CRC sensitivity to ferroptosis and supports tumor progression.",{"name":70,"@type":61,"acceptedAnswer":71},"Which upstream regulator is identified for SREBP2?",{"text":72,"@type":64},"β-catenin is identified as an upstream regulator that controls SREBP2 expression.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},344615,1790176179,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1099513958607,"https://ap-avatar.wpscdn.com/avatar/100002390cf8733938c?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778829742770036399","SREBP2 confers ferroptosis resistance by targeting GPX4 in colorectal cancer  \nHuage Zhong2,3 · Ruiqi Chen1 · Tianyu Chen2 · Min Lin1 · Siqi Wen1 · Man Zhang1 · Dejun Liu1 · Junfeng Yu2 · Jinchi Chen1 · Bei Yi1 · Rong Liang1 · Wei Jiang1 · Zhao Li1  \nReceived: 10 September 2025 / Accepted: 19 November 2025 / Published online: 10 January 2026 © The Author(s) 2025  \nAbstract  \nBackground The upregulated expression of sterol regulatory element-binding protein 2 (SREBP2) has been observed in multiple types of malignant cancers. Ferroptosis is a form of cell death that is iron-dependent and driven by the accumulation of lipid peroxides. It has recently garnered considerable attention in Colorectal cancer (CRC) research. This study aims to investigate the role of SREBP2 in CRC ferroptosis resistance and the underlying molecular mechanisms.  \nMethods SREBP2 expression was assessed in CRC. Functional assays were conducted in HT29 and RKO cells following SREBP2 knockdown or treatment with Betulin, the SREBP2 inhibitor. RNA-seq was used to screen the potential downstream targets of SREBP2 . Mechanistically, ferroptosis-related markers and rescue assays revealed the relation between SREBP2 and CRC ferroptosis resistance mediated by GPX4 expression regulation. Furthermore, ChIP and luciferase assays were used to confirm the upstream that regulates SREBP2 expression. Finally, subcutaneous tumorigenesis model was employed to evaluate the therapeutic potential of targeting SREBP2 in CRC.  \nResults The upregulated SREBP2 expression in CRC drives the proliferation, migration, and invasion ofCRC cells. Mechanistically, SREBP2 directly increases GPX4 transcription, thereby reducing the sensitivity of CRC to ferroptosis and facilitating CRC progression. Additionally, β-catenin was identified as an upstream regulator of SREBP2 . Inhibition of SREBP2 sensitizes CRC cells to ferroptosis and suppresses tumor growth.  \nConclusion SREBP2 enhances ferroptosis resistance in CRC by upregulating GPX4, thereby contributing to tumor progression. Our findings highlight SREBP2 as a potential therapeutic target and provide a rationale for the development of SREBP2-targeted strategies in colorectal cancer.  \nKeywords Colorectal cancer · SREBP2 · GPX4 · Ferroptosis · β-catenin  \nHuage Zhong, Ruiqi Chen and Tianyu Chen have contributed equally to this work.  \n􀀍 Zhao Li [zhaoli19890411@163.com](zhaoli19890411@163.com)  \n1 Department of Experimental Research, Guangxi Medical University Cancer Hospital, Nanning, China  \n2 Division of Colorectal and Anal Surgery, Department of Gastrointestinal Surgery, Guangxi Medical University Cancer Hospital, Nanning, China  \n3 Guangxi Clinical Research Center for Colorectal Cancer, Nanning, China  \nBackground  \nColorectal cancer (CRC) is a malignant neoplasm of the digestive system that significantly endangers human health, with high incidence and mortality rates. Currently, colorectal cancer accounts for 9.6% of global cancer cases and 9.3% of cancer-related deaths, ranking as the second leading cause of cancer mortality worldwide and remaining a major global health concern [1] . Although surgery, radiotherapy, chemotherapy, or their combination has reduced the mortality of colorectal cancer, advanced CRC patient prognosis remains suboptimal [2] . Therefore, a deeper understanding of the molecular mechanisms underlying colorectal cancer development is crucial for advancing its diagnosis and treatment.  \nRecently, ferroptosis has garnered considerable attention in cancer including CRC. Ferroptosis is a form of cell death that is iron-dependent and driven by the accumulation of lipid peroxides [3–5] . When levels of lipid reactive oxygen species (ROS) exceed the antioxidant capacity of glutathione peroxidase 4 (GPX4), cellular redox homeostasis collapses, ultimately leading to oxidative damage and ferroptosis [6, 7] . However, cancer cells have ferroptosis defense mechanisms for survival under oxidative stress [8–10] . Disruption o","cbCaiuqQ8jws7jgX","https://ap.wps.com/l/cbCaiuqQ8jws7jgX","pdf",8666721,17,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Background\n## Ferroptosis and GPX4 in CRC\n## Role of SREBP2 in cancer and ferroptosis\n## Study rationale","[{\"question\":\"What is the main goal of the study in CRC?\",\"answer\":\"To determine how SREBP2 contributes to ferroptosis resistance in colorectal cancer and to clarify the underlying molecular mechanism.\"},{\"question\":\"How does SREBP2 affect ferroptosis sensitivity in CRC cells?\",\"answer\":\"SREBP2 increases GPX4 transcription, which reduces CRC sensitivity to ferroptosis and supports tumor progression.\"},{\"question\":\"Which upstream regulator is identified for SREBP2?\",\"answer\":\"β-catenin is identified as an upstream regulator that controls SREBP2 expression.\"}]","SREBP2 confers ferroptosis resistance by targeting GPX4 in colorectal cancer | PDF",1790054657,43,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5719c39be2aeb6b2717449107e4755f8.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/acdf0625d340e064dd62a1ead8de1cd3.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9ad41e6bf1d1c02b9397dc2f5e6d17a1.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3115a844b6c4ef83ac397eda31bd68cf.webp",980,1301]